CN110408630B - Mycobacterium tuberculosis H37Rv encoding gene and application thereof - Google Patents

Mycobacterium tuberculosis H37Rv encoding gene and application thereof Download PDF

Info

Publication number
CN110408630B
CN110408630B CN201810402636.7A CN201810402636A CN110408630B CN 110408630 B CN110408630 B CN 110408630B CN 201810402636 A CN201810402636 A CN 201810402636A CN 110408630 B CN110408630 B CN 110408630B
Authority
CN
China
Prior art keywords
gene
sequence
mycobacterium tuberculosis
dna
primer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201810402636.7A
Other languages
Chinese (zh)
Other versions
CN110408630A (en
Inventor
徐平
张瑶
武舒佳
孙金帅
王富强
何崔同
常蕾
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Academy of Military Medical Sciences AMMS of PLA
Original Assignee
BEIJING PROTEOME RESEARCH CENTER
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BEIJING PROTEOME RESEARCH CENTER filed Critical BEIJING PROTEOME RESEARCH CENTER
Priority to CN201810402636.7A priority Critical patent/CN110408630B/en
Publication of CN110408630A publication Critical patent/CN110408630A/en
Application granted granted Critical
Publication of CN110408630B publication Critical patent/CN110408630B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention relates to a mycobacterium tuberculosis H37Rv coding gene and application thereof, in particular to a novel encoding gene Rv022 0229A (- | 274710-.

Description

Mycobacterium tuberculosis H37Rv encoding gene and application thereof
Technical Field
The invention relates to the field of gene detection, in particular to identification of pathogenic bacteria species.
Background
Mycobacterium Tuberculosis (MTB) is a pathogenic bacterium that causes tuberculosis in humans. It can invade all organs of the body, but pulmonary tuberculosis is the most common. Tuberculosis is an extremely important infectious disease so far and seriously threatens the life health of human beings. It is reported by WHO that about 800 new cases occur each year, and at least 300 million people die from the disease. The clinical bacterial strain of MTB is difficult to culture, slow in growth, capable of cross-infecting with other mycobacteria, difficult to distinguish between tuberculosis and other respiratory tract infection symptoms and the like, and brings great difficulty to clinical rapid diagnosis and treatment. Therefore, the establishment of a quick, accurate, specific, sensitive and cheap tuberculosis detection method is a necessary premise for effectively treating and controlling tuberculosis spreading, and is a new challenge and a new task for detecting mycobacterium in clinical laboratories.
Mycobacterium tuberculosis complex (MTBC) includes the Mycobacterium groups m.tuberculosis, m.africanum, m.orygis, m.bovis, m.microti, m.canettii, m.caprae, m.pinnipedii, m.subcatetate, m.mungi, which all cause tuberculosis in humans and other life forms. At present, the domestic and foreign MTBC identification method is mainly divided into the following three categories: traditional separation culture method; molecular level detection (IS6110, restriction fragment length polymorphism analysis, multi-site variable number repeat polymorphism analysis, etc.); a method for analyzing the components of a microorganism (fatty acid, mycolic acid) by chromatography. The three methods have respective advantages, but have disadvantages, such as long separation culture period and low thallus culturable rate; at present, the molecular level detection is poor in specificity, sensitivity and simplicity; the analysis cost of the thallus component characteristics is high, and the operation is complex.
MTB H37Rv completed whole genome sequencing in 1998, the MTB strain that completed whole genome sequencing the earliest. From this point on, researchers in various countries are perfecting and supplementing H37Rv gene annotation databases based on strategies such as algorithm optimization, annotation software updating, transcriptomics and proteomics. However, since MTB belongs to prokaryotes, annotation errors (over-annotation, gene boundary error, ORF initiation, termination site error, alternative splicing, ribosome translocation, missing annotation) may still exist in genome annotation due to the inherent shortcomings of the prokaryote genome annotation technology, which brings trouble to deep and accurate analysis of biological mechanisms. In order to solve the problem, proteomics (proteomics) has been used for correcting the annotated gene of H37Rv, however, high-proportion false positive, difficulty in annotated gene prediction, new gene verification, new gene function analysis and application thereof, and the like, are problems faced in the field.
In general, the traditional mycobacterium tuberculosis complex (MTBC) identification strategy has the defects of long period, tedious steps, low specificity and sensitivity and the like. In order to further perfect re-annotation of the H37Rv whole genome, missing annotation genes in H37Rv are found, the H37Rv whole genome missing annotation genes and application technologies thereof in MTBC molecular identification are effectively protected, and a method for quickly and accurately identifying the MTBC group by using the H37Rv new genes is imperatively developed.
Disclosure of Invention
An object of the invention is to provide a new encoding gene of mycobacterium tuberculosis H37Rv, which is H37Rv leaky annotation encoding gene Rv0229A (- |274710 |) -274904|), which can be used as a barcode molecular marker of mycobacterium tuberculosis complex and used for detecting mycobacterium tuberculosis complex, and the sequence of the new encoding gene is shown as SEQ ID NO. 1.
Other objects of the present invention include providing specific PCR primers useful for amplifying the above-described encoding genes and providing a method of detecting or identifying the presence of a binding Mycobacterium complex in a sample; the invention also provides a detection kit related to the coding gene and application of the gene.
According to one aspect of the invention, by comparing proteomic research techniques, a protein coding sequence of H37Rv that is difficult to find by genetic prediction software was discovered that effectively distinguishes MTBC from other species of the same genus. The gene is a missing annotation gene of Mycobacterium tuberculosis (Mycobacterium tuberculosis H37Rv), namely Rv0229A (- | 274710-. Comparative genomics studies show that the gene sequence can distinguish the Mycobacterium tuberculosis complex (MTBC) strain from other species of Mycobacterium.
Specifically, a primer capable of realizing specific amplification on the Rv0229A (-274710) -274904| gene of MTBC is designed, namely the primer provided by the invention, and the sequence of the primer is as follows:
F:5’-GGCATTACCTCCACATCCAC-3’；
R:5’-CCTCAGCCAACGGTTCCA-3’。
according to the existence of the gene DNA sequence PCR product in the sample to be detected or the difference of the DNA sequence, the MTBC can be quickly and accurately identified.
According to another aspect of the present invention, based on the above-mentioned new standard encoding gene of Mycobacterium tuberculosis H37Rv, the present invention specifically establishes a method for detecting or identifying Mycobacterium tuberculosis complex, comprising the following steps:
(1) separating and extracting genome DNA from a sample to be detected;
(2) and (2) performing PCR amplification by using the DNA obtained in the step (1) as a template and adopting the following primers:
F:5’-GGCATTACCTCCACATCCAC-3’(SEQ ID NO.4)；
R:5’-CCTCAGCCAACGGTTCCA-3’(SEQ ID NO.5)。
(3) performing gel electrophoresis analysis or sequencing on the DNA product obtained by amplification in the step (2);
(4) and (3) comparing the result of the step (3) with the barcode gene Rv0229A (- | 274710-.
Further, the detection method is characterized in that electrophoresis analysis is performed on the PCR product primarily according to the DNA bar code principle, and if the strain to be detected does not have a target band, the strain is not MTBC; if the band exists, further sequencing verification can be carried out, the sequence obtained by sequencing and the standard sequence of Rv0229A (-274710) -274904| of H37Rv are subjected to homologous comparison and comparison to obtain the similarity between the sequences, and if the sequence homology is more than 99%, the strain can be judged to be MTBC; and (3) distinguishing the MTBC family from nontuberculous mycobacteria, common respiratory pathogenic bacteria and common respiratory viruses according to the clustering condition of the DNA barcode sequence of the strain to be identified and the standard sequence.
The detection method can be used for strain identification research of the mycobacterium tuberculosis complex and can also be used for clinical rapid inspection. The sample to be detected can be H37Rv strain, other MTBC, nontuberculous mycobacteria, respiratory tract common pathogenic bacteria and respiratory tract common virus strain; or directly using sputum, saliva or blood of tuberculosis and other respiratory patients.
Based on the above method, the present invention also provides a detection kit, wherein the kit contains a reagent for detecting the novel standard encoding gene of Mycobacterium tuberculosis H37Rv in a container, and simultaneously provides manufacturing, using and marketing information about the medicine or biological product, which can be approved by a government drug administration. For example, the reagent for directly detecting the Rv0229A (- |274710-274904|) gene in the sample after PCR amplification may comprise one or more of amplification primers, dNTPs, DNA polymerase used for PCR reaction and its buffer, reagents required for enzyme digestion reaction and/or sequencing reaction, etc. It is known to those skilled in the art that the above components are merely illustrative, and for example, the primers may employ the specific PCR primers described above, and the DNA polymerase used for the PCR reaction is an enzyme capable of being used for PCR amplification. The detection of the encoding gene of the present invention can also be provided in the form of an integrated, e.g., gene chip.
Has the advantages that: the invention provides a standard gene and a molecular identification method for molecular identification of Mycobacterium tuberculosis complex (MTBC), wherein the gene can effectively distinguish MTBC from other species of the same genus, the identification method using the gene overcomes the defects of primer design multiplicity, poor result repeatability and the like in the existing identification process of the Mycobacterium tuberculosis complex, has the characteristics of universality, easy amplification and easy comparison, can accurately identify the class from other mycobacteria with close relativity or other respiratory tract infectious germs, and provides powerful technical means and research tools for the epidemiological investigation and the rapid diagnosis and identification of clinical tuberculosis patients.
Drawings
FIG. 1: evidence of peptide profile matching supporting the discovery of new coding genes;
a, a first peptide segment B, C, a second peptide segment D, a third peptide segment
FIG. 2: comparing the mass spectrogram of the synthesized peptide fragment with the mass spectrogram of the original identified peptide fragment;
a, a first peptide segment B, a second peptide segment C and a third peptide segment
FIG. 3: a corresponding diagram of a protein sequence coded by ORF of the peptide fragment locus region; the underlined part is the peptide identified in proteomics and verified by the synthetic peptide;
FIG. 4: comparing the homology of the Rv0229A (- |274710-274904|) standard gene sequence;
FIG. 5: the result of the protein sequence BLASTP corresponding to the Rv0229A (- |274710-274904|) gene of the H37Rv strain;
FIG. 6: the result of agarose gel electrophoresis of the PCR amplification product of the Rv0229A (-274710-274904-);
the specific information of each lane sample is shown in Table 1.
FIG. 7: the PCR amplification sequencing result of the Rv0229A (-274710-274904) gene is compared with a standard sequence.
Detailed Description
The invention is further described with reference to specific embodiments, but the scope of the claims is not limited thereto. The reagents used in the present invention are all commercially available.
Example 1: search for genes encoding missing release of the genome of strain H37Rv
1.1 high coverage proteomic validation of the genome of the H37Rv strain
The deep coverage study of proteome was performed on the H37Rv strain using the high coverage proteome technique. Annotated encoding gene validation was performed on its genome using the pFind 3 engine based on the Tuberculosis (20160307) database. To find new protein coding regions, we performed six-reading-frame database translation of H37Rv in the genome-wide (NC _000962.3) file published at NCBI using pAnno software based on proteomic technology, and identified new peptide fragments and new proteins using this database for mass spectrometry data. To reduce the false positive rate, we used 3 filtering methods to separately estimate class FDR for the annotated and new peptide fragments, S-FDR, T-FDR I and T-FDR II, respectively, during the data filtering.
Through data analysis, a total of 3238H 37Rv annotated genes are identified, and the coverage is as high as more than 80% of the strain, which is the largest mass spectrum data of the H37Rv protein reported so far. In addition, we obtained new peptide fragments after 3 FDRs ≤ 1 filtration. In order to further ensure the quality of the new peptide fragments, spectrogram quality screening is carried out on spectrograms corresponding to the new peptide fragments left after filtration, and finally some peptide fragments with good spectrogram quality are reserved. To further investigate that these peptides with higher spectral quality were not due to single amino acid mutations in the annotated peptide, we performed amino acid mutation checks to ensure that these new peptides were newly identified peptides of H37 Rv.
1.2 verification of encoded protein and database of Rv0229A (- |274710-
After high coverage proteome verification, we find some suspected new peptide fragments which are leaked to release, and perform peptide fragment synthesis verification on the suspected new peptide fragments with high reliability, and score more than or equal to 0.9 according to the similarity of the original spectrum and the synthesized spectrum of the new peptide fragments as a similarity threshold, and after scoring and screening, 3 peptide fragments pass through verification and correspond to a new Open Reading Frame (ORF), namely the potential leaked to release genes of the current H37Rv strain.
Among them, we found a novel missed-release gene Rv0229A (- |274710 | -274904|), the same sequence of which was annotated as a hyposynthetic protein in the NCBI database by BLASTP comparison, and the close sequence of which was annotated as an Antitoxin in the M.tubocus Beijing/MYC004 and M.tubocus Bir 88 strains, and possibly associated with the pathogenicity of MTB bacterium, so that the gene belongs to the missed-release gene in H37 Rv. As shown in FIG. 1, the detected peptides TELGTTTIKDTVNAALR (SEQ ID NO.6), VAAALDTLAAAPPEDR (SEQ ID NO.7) and HLVDIDEQALNMAR (SEQ ID NO.8) correspond to the new gene Rv0229A (- |274710 | -) 274904, the spectrogram quality is good, b/y ions are continuously matched, the peak signal is low, and the result is very reliable.
To further confirm this identification, we chemically synthesized the peptide according to the amino acid sequence of our newly identified peptide and generated a secondary spectrum of the synthesized peptide using the mass spectrometry conditions described above.
Our high energy collision MS on synthetic peptide fragments2Verification is carried out, and the primary parent ions and the secondary daughter ions both accord with theoretical values, so that the sequence of the synthesized peptide fragment is correct; on this basis, we manually examined MS of synthetic peptides of novel peptide sequences identified from large-scale proteomic data2And the large-scale identification of the new peptide fragment spectrum almost completely conforms to the two spectra, wherein the TELGTTTIKDTVNAALR similarity cosin value is 0.98, the VAAALDTLAAAPPEDR daughter ion cosin value is 0.94, and the HLVDIDEQALNMAR daughter ion cosin value is 0.99, which proves that the new peptide fragment identified from H37Rv is correct. (FIG. 2).
After confirming the sequence of the peptide fragment to be released, according to the gene position of the peptide fragment, taking the region included by the former stop codon and the latter stop codon as a boundary, obtaining the Open Reading Frame (ORF) DNA sequence containing the new peptide fragment to be released, as shown in SEQ ID NO. 2.
TGATATATACTCCGATTCATGGCGAAACATCTCGTCGACATCGACGAGCAGGCTTTAAACATGGCTCGTACAGAATTGGGCACGACGACGATCAAAGACACCGTCAACGCGGCCCTGCGGCAAGCCACGTCTCAGCGAGTTCAACGCGTCGCCGCCGCTCTCGACACGCTGGCCGCCGCACCGCCAGAGGACCGCGCCGAAGCATGGCGCTGA(SEQ ID NO.2)
The correspondence between the open reading frame code and the amino acid sequence is shown in FIG. 3.
Further translation verification revealed that the authentic gene sequence (SEQ ID NO.1) was found from the above-mentioned open reading frame DNA (SEQ ID NO.2)ATGAt the beginning, 195bp in total encodes 64 amino acids, and the theoretical molecular weight is 6.97kDa, namely the Rv0229A (- | 274710-.
ATGGCGAAACATCTCGTCGACATCGACGAGCAGGCTTTAAACATGGCTCGTACAGAATTGGGCACGACGACGATCAAAGACACCGTCAACGCGGCCCTGCGGCAAGCCACGTCTCAGCGAGTTCAACGCGTCGCCGCCGCTCTCGACACGCTGGCCGCCGCACCGCCAGAGGACCGCGCCGAAGCATGGCGCTGA(SEQ ID NO.1)
The theoretical coding product amino acid sequence of the gene is shown as SEQ ID NO. 3:
MAKHLVDIDEQALNMARTELGTTTIKDTVNAALRQATSQRVQRVAAALDTLAAAPPEDRAEAWR(SEQ ID NO.3)
the amino acid sequence of the theoretical gene-encoded product shown in SEQ ID NO.3 was subjected to NCBI-BLASTP analysis, and the same or similar sequences thereof were annotated as Antitoxin proteins in RefSeq database, M.tubocussis Beijing/MYC004 and M.tubocussis Bir 88 strains, and the adjacent gene Rv0229c was a Toxin protein, and this missed-release gene and Rv0229c constituted just one pair of Toxin-Antitoxin systems (Toxin-Antitoxin systems) and were probably related to the pathogenicity of MTB bacteria (see FIG. 5). It is well shown that the Rv0229A (- |274710-274904|) gene product we detected was missing annotations in the H37Rv strain database.
We carried out comparative genome local BLAST analysis on the DNA sequence of the Rv0229A (- |274710-274904|) gene, as shown in FIG. 5, and the result shows that the Rv0229A (- |274710-274904|) gene sequence belongs to MTBC family specific genes, and has no sequences with higher homology in other species, which means that the Rv0229A (- |274710-274904|) gene sequence found in the H37Rv strain has better sequence specificity, and can distinguish MTBC from other mycobacteria and other respiratory tract infection bacteria in the same genus.
Example 2: method for establishing and identifying MTBC complex group
(1) Designing a primer:
based on the CDS sequence of the Rv0229A (- |274710-274904|) gene shown in SEQ ID NO.1, a PCR primer is designed by using Oligo7.0, and the primer sequence is as follows:
F:5’-GGCATTACCTCCACATCCAC-3’(SEQ ID NO.4)；
R:5’-CCTCAGCCAACGGTTCCA-3’(SEQ ID NO.5)
the position relationship between the above primers and the Rv0229A (- |274710-274904|) gene is shown as follows, wherein the single-line marks are marked under the corresponding positions of the primers, and the gray background is the complete ORF sequence of the missed-release gene Rv0229A (- |274710-274904 |).
GGCATTACCTCCACATCCACAACGACGTCATCCCCGCACTGAAGCAGCACGGCGTCACCGACGAGCAGCTGCACACCATGCTCGTCGACAACCCGCGCCGCATCTTCGAGCGGCAGGGCGGCTATCAGTGAGACAGCCGCGCCGGGCGAATGCCATGGGCTTGGCATTGTGCATATATATCGGCTCCTTATTGATATATACTCCGATTCATGGCGAAACATCTCGTCGACATCGACGAGCAGGCTTTAAACATGGCTCGTACAGAATTGGGCACGACGACGATCAAAGACACCGTCAACGCGGCCCTGCGGCAAGCCACGTCTCAGCGAGTTCAACGCGTCGCCGCCGCTCTCGACACGCTGGCCGCCGCACCGCCAGAGGACCGCGCCGAAGCATGGCGCTGAAATATCTTCTCGACACCAGCGTGATCAAAAGGCTCAGCCGGCCCGCCGTGCGGCGGGCGGTGGAACCGTTGGCTGAGG(SEQ ID NO.9)
(2) Extracting total DNA of strains to be detected including M.tuberculosis H37Rv, wherein 40 standard strains of mycobacterium are preserved by China medical bacterial strain preservation management center (CMCC), the other 16 non-tuberculous mycobacteria are clinical isolates of 309 hospital of China people' S liberation military, completing the work of sequencing and comparing strains 16S RNA genes and submitting NCBI sequences, and the strains to be detected are shown in Table 1:
TABLE 1 related strains selected
Figure BDA0001646084470000071
Figure BDA0001646084470000081
Figure BDA0001646084470000091
(3) The DNA fragment was amplified and subjected to Polymerase Chain Reaction (PCR) using the above F/R primer.
PCR System (25. mu.L) as dd H2O (9.5. mu.L), 2XTaq PCR MasterMix (TIANGEN, 12.5. mu.L), primer F (10. mu.M, 1. mu.L), primer R (10. mu.M, 1. mu.L), DNA template (1. mu.L);
and (3) amplification procedure: pre-denaturation at 94 ℃ for 3min, denaturation at 94 ℃ for 30s, annealing at 58 ℃ for 30s, extension at 72 ℃ for 1min, 35 cycles, and extension at 72 ℃ for 5 min.
(4) And (4) detecting the amplified product by electrophoresis in agarose gel and 1 xTBE electrophoresis solution. As a result, as shown in FIG. 6, an amplification band appeared at 482bp in MTBC and positive control group, and the amplification result agreed with the expectation, and the specificity was 96.7%.
(5) To further verify the sequence of the amplified DNA, we sequenced the amplified sequence and compared it with the missing release sequence, as shown in FIG. 7, which is a perfect match to the expectation and correct sequence, which further verifies the presence of the new missing release gene. This shows that the method for identifying MTBC complex group based on Rv0229A (- |274710-274904|) gene is true and reliable.
SEQUENCE LISTING
<110> Peking proteome research center
<120> Mycobacterium tuberculosis H37Rv encoding gene and application thereof
<130> BJ1936-18P121914
<160> 9
<170> PatentIn version 3.3
<210> 1
<211> 195
<212> DNA
<213> Artificial
<220>
<223> Mycobacterium tuberculosis H37Rv encoding gene Rv0229A (- |274710-
<400> 1
atggcgaaac atctcgtcga catcgacgag caggctttaa acatggctcg tacagaattg 60
ggcacgacga cgatcaaaga caccgtcaac gcggccctgc ggcaagccac gtctcagcga 120
gttcaacgcg tcgccgccgc tctcgacacg ctggccgccg caccgccaga ggaccgcgcc 180
gaagcatggc gctga 195
<210> 2
<211> 213
<212> DNA
<213> Artificial
<220>
<223> open reading frame DNA sequence comprising peptide fragment with missing annotation
<400> 2
tgatatatac tccgattcat ggcgaaacat ctcgtcgaca tcgacgagca ggctttaaac 60
atggctcgta cagaattggg cacgacgacg atcaaagaca ccgtcaacgc ggccctgcgg 120
caagccacgt ctcagcgagt tcaacgcgtc gccgccgctc tcgacacgct ggccgccgca 180
ccgccagagg accgcgccga agcatggcgc tga 213
<210> 3
<211> 64
<212> PRT
<213> Artificial
<220>
<223> Rv0229A (-274710-274904 |) gene theoretical coding product amino acid sequence
<400> 3
Met Ala Lys His Leu Val Asp Ile Asp Glu Gln Ala Leu Asn Met Ala
1 5 10 15
Arg Thr Glu Leu Gly Thr Thr Thr Ile Lys Asp Thr Val Asn Ala Ala
20 25 30
Leu Arg Gln Ala Thr Ser Gln Arg Val Gln Arg Val Ala Ala Ala Leu
35 40 45
Asp Thr Leu Ala Ala Ala Pro Pro Glu Asp Arg Ala Glu Ala Trp Arg
50 55 60
<210> 4
<211> 20
<212> DNA
<213> Artificial
<220>
<223> F primer sequences
<400> 4
ggcattacct ccacatccac 20
<210> 5
<211> 18
<212> DNA
<213> Artificial
<220>
<223> R primer sequences
<400> 5
cctcagccaa cggttcca 18
<210> 6
<211> 17
<212> PRT
<213> Artificial
<220>
<223> first missing annotation peptide fragment
<400> 6
Thr Glu Leu Gly Thr Thr Thr Ile Lys Asp Thr Val Asn Ala Ala Leu
1 5 10 15
Arg
<210> 7
<211> 16
<212> PRT
<213> Artificial
<220>
<223> second omission annotation of peptide fragments
<400> 7
Val Ala Ala Ala Leu Asp Thr Leu Ala Ala Ala Pro Pro Glu Asp Arg
1 5 10 15
<210> 8
<211> 14
<212> PRT
<213> Artificial
<220>
<223> third missing annotation peptide fragment
<400> 8
His Leu Val Asp Ile Asp Glu Gln Ala Leu Asn Met Ala Arg
1 5 10
<210> 9
<211> 482
<212> DNA
<213> Artificial
<220>
<223> demonstration of integration sequence of upstream and downstream primers with Rv0229A (- |274710-274904|) Gene
<400> 9
ggcattacct ccacatccac aacgacgtca tccccgcact gaagcagcac ggcgtcaccg 60
acgagcagct gcacaccatg ctcgtcgaca acccgcgccg catcttcgag cggcagggcg 120
gctatcagtg agacagccgc gccgggcgaa tgccatgggc ttggcattgt gcatatatat 180
cggctcctta ttgatatata ctccgattca tggcgaaaca tctcgtcgac atcgacgagc 240
aggctttaaa catggctcgt acagaattgg gcacgacgac gatcaaagac accgtcaacg 300
cggccctgcg gcaagccacg tctcagcgag ttcaacgcgt cgccgccgct ctcgacacgc 360
tggccgccgc accgccagag gaccgcgccg aagcatggcg ctgaaatatc ttctcgacac 420
cagcgtgatc aaaaggctca gccggcccgc cgtgcggcgg gcggtggaac cgttggctga 480
gg 482

Claims (3)

1. A method for rapidly detecting and/or identifying whether a Mycobacterium tuberculosis complex class exists in a sample to be detected comprises the following steps:
(1) separating and extracting genome DNA from a sample to be detected;
(2) adding an amplification primer by taking the DNA obtained in the step (1) as a template to perform polymerase chain reaction;
(3) performing gel electrophoresis analysis or sequencing on the DNA product obtained by amplification in the step (2);
(4) judging whether the gel electrophoresis target strip result in the step (3) is at the size of 482bp, comparing the sequencing result with the sequence shown in SEQ ID NO.9, and judging whether the Mycobacterium tuberculosis complex exists in the sample to be detected according to the homology;
wherein the sequence of the amplification primer in the step (2) is as follows:
F: 5’- GGCATTACCTCCACATCCAC -3’；
R: 5’- CCTCAGCCAACGGTTCCA -3’；
the method is not used for the diagnostic treatment of diseases.
2. A specific PCR primer for the genomic DNA amplification of a sample to be tested in the method of claim 1, wherein the sequence of the primer is as follows:
F: 5’- GGCATTACCTCCACATCCAC -3’；
R: 5’- CCTCAGCCAACGGTTCCA -3’。
3. a test kit comprising the specific PCR primers of claim 2.
CN201810402636.7A 2018-04-28 2018-04-28 Mycobacterium tuberculosis H37Rv encoding gene and application thereof Active CN110408630B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810402636.7A CN110408630B (en) 2018-04-28 2018-04-28 Mycobacterium tuberculosis H37Rv encoding gene and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810402636.7A CN110408630B (en) 2018-04-28 2018-04-28 Mycobacterium tuberculosis H37Rv encoding gene and application thereof

Publications (2)

Publication Number Publication Date
CN110408630A CN110408630A (en) 2019-11-05
CN110408630B true CN110408630B (en) 2021-02-19

Family

ID=68357080

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810402636.7A Active CN110408630B (en) 2018-04-28 2018-04-28 Mycobacterium tuberculosis H37Rv encoding gene and application thereof

Country Status (1)

Country Link
CN (1) CN110408630B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113278633B (en) * 2020-02-20 2022-10-28 北京蛋白质组研究中心 Mycobacterium tuberculosis H37Rv gene, and coding protein and application thereof
CN113373162A (en) * 2020-03-09 2021-09-10 北京蛋白质组研究中心 Mycobacterium tuberculosis H37Rv novel gene Rv0229A and encoding protein and application thereof
CN113403327A (en) * 2020-03-17 2021-09-17 北京蛋白质组研究中心 Mycobacterium tuberculosis H37Rv new gene Rv2706 and coding protein and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1715422A (en) * 2004-06-30 2006-01-04 中国农业科学院哈尔滨兽医研究所 Novel Mycobacterium bovis and the method for quick identification of mycobacterium tuberculosis and application
CN103014135B (en) * 2011-09-22 2016-02-10 上海市肺科医院 A kind of method identifying mycobacterium tuberculosis
CN104561245A (en) * 2013-10-16 2015-04-29 复旦大学 Rapid identification method and kit for MTBC (mycobacterium tuberculosis complex)

Also Published As

Publication number Publication date
CN110408630A (en) 2019-11-05

Similar Documents

Publication Publication Date Title
CN110408630B (en) Mycobacterium tuberculosis H37Rv encoding gene and application thereof
CN110408629B (en) Mycobacterium tuberculosis H37Rv encoding gene and application thereof
Jiang et al. Comparison of the proteome of isoniazid-resistant and-susceptible strains of Mycobacterium tuberculosis
López et al. Diagnosis and detection of the main bacterial pathogens of stone fruit and almond
CN111378774A (en) Primer group, kit and method for rapidly detecting Listeria monocytogenes
CN108165561B (en) Mycobacterium tuberculosis H37Rv encoding gene and application thereof
CN108004253B (en) Mycobacterium tuberculosis H37Rv encoding gene and application thereof
CN108165562B (en) Mycobacterium tuberculosis H37Rv encoding gene and application thereof
CN108165564B (en) Mycobacterium tuberculosis H37Rv encoding gene and application thereof
Spinali et al. MICROBIAL TYPING BY MALDI-TOF MS: 4 DO WE NEED GUIDANCE FOR DATA INTERPRETATION? 5
CN110408632B (en) Mycobacterium tuberculosis H37Rv encoding gene and application thereof
CN108165560B (en) Mycobacterium tuberculosis H37Rv encoding gene and application thereof
CN108165565B (en) Mycobacterium tuberculosis H37Rv encoding gene and application thereof
CN110408631B (en) Mycobacterium tuberculosis H37Rv encoding gene and application thereof
CN108165563B (en) Mycobacterium tuberculosis H37Rv encoding gene and application thereof
RAO Infection of Mycobacterium mageritense at surgical site: a first case report of India
CN115992267A (en) Primer group, kit and method for detecting multiple pathogenic bacteria with high flux and high precision
CN110343706A (en) Mycobacterium tuberculosis H37Rv encoding gene and its application
CN113174443B (en) Mycobacterium identification method and biological material thereof
Mironov et al. Multilocus sequence-typing scheme for Borrelia miyamotoi—the erythema-free ixodid tick-borne borreliosis pathogens
CN112048552B (en) Intestinal flora for diagnosing myasthenia gravis and application thereof
CN113667767B (en) Method for rapidly and high-flux detection of drug resistance of helicobacter pylori
Zhu et al. Metataxonomics of Internal Transcribed Spacer amplicons in cerebrospinal fluid for diagnosing and genotyping of cryptococcal meningitis
CN117230090A (en) Encoding gene of mycobacterium abscessus and application thereof
US20230326600A1 (en) A method for determining a diagnostic outcome

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20240131

Address after: 100850 No. 27 Taiping Road, Beijing, Haidian District

Patentee after: ACADEMY OF MILITARY MEDICAL SCIENCES

Country or region after: China

Address before: Building 1, No.33, kekeyuan Road, Changping District, Beijing

Patentee before: BEIJING PROTEOME RESEARCH CENTER

Country or region before: China

TR01 Transfer of patent right